David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
426
PUT
Adobe
ADBE
$110B
| $45.8M | 0.05% |
138,800
+15,700
| +13% | +$4.62M |
|
|
PRSP
427
DELISTED
Perspecta Inc. Common Stock
PRSP
| $45.5M | 0.05% |
1,720,524
+505,230
| +42% | +$13.5M |
|
428
Karyopharm Therapeutics
KPTI
$42.4M
| $45.3M | 0.05% |
157,701
+65,633
| +71% | +$14.2M |
|
|
ZIONW
429
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
| $45.1M | 0.05% |
2,308,700
| – | – |
|
430
CALL
Snap
SNAP
$9.22B
| $45M | 0.05% |
2,756,700
-298,300
| -10% | -$4.39M |
|
431
CME Group
CME
$100B
| $45M | 0.05% |
224,013
+18,218
| +9% | +$3.74M |
|
432
Chevron
CVX
$399B
| $44.9M | 0.05% |
372,721
-39,031
| -9% | -$4.6M |
|
433
Plains GP Holdings
PAGP
$5.4B
| $44.9M | 0.05% |
+2,368,792
| New | +$44.4M |
|
434
SLB Ltd
SLB
$79.8B
| $44.7M | 0.05% |
1,110,774
-1,431,160
| -56% | -$51.1M |
|
435
PUT
GE Aerospace
GE
$354B
| $44.6M | 0.05% |
800,982
+196,564
| +33% | +$10.2M |
|
436
CALL
Costco
COST
$430B
| $44.5M | 0.05% |
151,500
+37,000
| +32% | +$11M |
|
437
Tapestry
TPR
$26.4B
| $44.2M | 0.05% |
1,640,148
+156,430
| +11% | +$4.08M |
|
438
PUT
Pfizer
PFE
$160B
| $44.2M | 0.05% |
1,188,174
-583,284
| -33% | -$20.8M |
|
|
EXAS
439
DELISTED
Exact Sciences
EXAS
| $44.1M | 0.05% |
477,244
-572,155
| -55% | -$50.3M |
|
440
Hyatt Hotels
H
$16.9B
| $44.1M | 0.05% |
491,868
-261,911
| -35% | -$20.4M |
|
441
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $44M | 0.05% |
1,134,654
+200,000
| +21% | +$8.05M |
|
442
Arrowhead Research
ARWR
$12.2B
| $44M | 0.05% |
692,895
-43,341
| -6% | -$2.15M |
|
|
CTLT
443
DELISTED
CATALENT, INC.
CTLT
| $43.9M | 0.05% |
778,904
-154,349
| -17% | -$7.87M |
|
444
TechnipFMC
FTI
$29.7B
| $43.8M | 0.05% |
2,743,038
+2,173,367
| +382% | +$33.7M |
|
|
TWOU
445
DELISTED
2U Inc
TWOU
| $43.6M | 0.05% |
60,638
+28,522
| +89% | +$17.7M |
|
446
Western Union
WU
$2.3B
| $43.6M | 0.05% |
1,626,936
+302,603
| +23% | +$7.85M |
|
447
Wayfair
W
$14.1B
| $43.5M | 0.05% |
481,825
-1,377,051
| -74% | -$128M |
|
|
WBA
448
DELISTED
Walgreens Boots Alliance
WBA
| $43.5M | 0.05% |
737,620
-839,786
| -53% | -$48.4M |
|
449
CALL
Amgen
AMGN
$240B
| $43.3M | 0.05% |
179,800
+113,600
| +172% | +$25M |
|
450
Tractor Supply
TSCO
$18.5B
| $43.3M | 0.05% |
2,318,420
-84,815
| -4% | -$1.61M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.